Experiment 68252
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Curcuma longa (ZINGIBERACEAE) |
| Citation | RAMIREZ-BOSCA,A: SOLER,A: CARRION,MA: DIAZ-ALPERI,J: BERND,A: QUINTANILLA,C: ALMAGRO,EQ: MIQUEL,J:. (2000). AN HYDROALCOHOLIC EXTRACT OF CURCUMA LONGA LOWERS THE APO B/APO A RATIO IMPLICATIONS FOR ATHEROGENESIS PREVENTION.. 119(1/2) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE PRESENT STUDY SHOWS THAT A DAILY ORAL ADMINSTRATION OT THE EXTRACT DECREASES SIGNIFICANTLY THE LDL AND APO B AND INCREASES THE HDL AND APO A OF HEALTHY SUBJECTS (N=30). THIS AND RECENT DATA ON THE INCREASED ANTI-ATHEROGENIC ACTION OF THE PHYSIOLOGICAL ANTIOXIDANT TOCOPHEROL IN THE PRESENCE OF PHENOLIC CO-ANTIXODIANT (WHICH ELIMINATE THE TOCOPHEROXYL RADICAL), JUSTIFIES PLANNED CLINICAL RESEARCH TO TEST THE USEFULNES SOF THE CURCUMA EXTRACT AS A CO-ANTIOXIDANT COMPLEMENT TO STANDARD TREATMENT TO PREVENT OR RETARD ATHEROSCLEROSIS. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |